Fas/Fas ligand up-regulation and BCL-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 2199-2203

  Mitsiades, Nicholas ^a,b   Poulaki, Vassiliki ^a   Kotoula, Vassiliki ^a   Mastorakos, George ^b   Tseleni Balafouta, Sophia ^c   Koutras, Demetrios A ^b   Tsokos, Maria ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Evgenidion Hospital   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CLINICAL ARTICLE; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; THYROID FOLLICLE;

ADOLESCENT; ADULT; ANTIGENS, CD95; APOPTOSIS; CROSS-LINKING REAGENTS; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0031790839     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.2199     Document Type: Article

References (29)

1. Rapoport B. 1991 Pathophysiology of Hashimoto's thyroiditis and hypothyroidism. Annu Rev Med. 42:91-96.
2. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sato H, Ohtaki S. 1995 Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity. 20:231-236.
3. Thompson CB. 1995 Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
4. Oehm A, Berhmann I, Falk W, et al. 1992 Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/NGF receptor superfamily. J Biol Chem. 267:10709-10715.
5. Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, Ota Z. 1995 Apoptosis in thyroid diseases: a histochemical study. Endocr J. 42:193-201.
6. Kawakami A, Eguchi K, Matsuoka N, et al. 1996 Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology. 137:3163-3169.
7. Suda T, Takahashi T, Golstein P, Nagata S. 1993 Molecular cloning and expression of the Fas ligand; a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
8. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. 1995 A role for CD95 ligand in preventing graft rejection. Nature. 377:630-632.
9. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. 1995 Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
10. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S. 1996 Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab. 81:3119-3122.
11. Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL. 1997 Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab. 82:3173-3175.
12. Giordano C, Stassi G, De Maria R, et al. 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 275:960-963.
13. Krajewski S, Bodrug S, Krajewska M, et al. 1995 Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol. 146:1309-1319.
14. Pollina L, Pacini F, Fontanini G, Vignati S, Bevilacqua G, Basolo F. 1996 Bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. Br J Cancer. 73:139-143.
15. Cory S. 1995 Regulation of lymphocyte survival by the Bcl-2 gene family. Annu Rev Immunol. 13:513-543.
16. Suzuki A, Matsuzawa A, Iguchi T. 1996 Down-regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene. 13:31-37.
17. Chetty R, O' Leary JJ, Biddolph SC, Gatter KC. 1995 Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. J Clin Pathol. 48:239-241.
18. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. 1995 Autocrine T-cell suicide mediated by APO1/(Fas/CD95). Nature. 373:438-441.
19. Brunner T, Mogil RJ, LaFace D, et al. 1995 Cell-autonomous Fas (CD95), Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:441-444.
20. Ju ST, Panka DJ, Cui H, et al. 1995 Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
21. Ajjan RA, Watson PF, McIntosh RS, Weetman AP. 1996 Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol. 105:523-528.
22. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. 1994 Anti-Fas/Apol antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest. 94:954-964.
23. Maciejewski J, Selleri C, Anderson S, Young NS. 1995 Fas antigen expression on CD34+ human bone marrow cells is induced by interferon and TNF and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 85:3183-3190.
24. Keane M, Ettenberg S, Lowrey G, Russell E, Lipkowitz S. 1996 Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56:4791-4798.
25. Wu Z, Podack ER, McKenzie JM, Olsen KJ, Zakarija M. 1994 Perform expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin Exp Immunol. 98:470-477.
26. Arscott PL, Knapp J, Rymaszewski M, et al. 1997 Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology. 138:5019-5027.
27. Kong L, Ogawa N, Nakabayashi T. 1997 Fas and FasL expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 40:87-97.
28. Chervonsky AV, Wang Y, Wong FS, et al. 1997 The role of Fas in autoimmune diabetes. Cell. 89:17-24.
29. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. 1996 Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 180:152-159.